Works by Park, Eunhyang


Results: 31
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Reply to: Comments on "Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045".

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 4, p. 764, doi. 10.1002/ijc.34786
    By:
    • Kim, Yoo‐Na;
    • Joung, Je‐Gun;
    • Park, Eunhyang;
    • Kim, Jae‐Weon;
    • Lee, Jung Bok;
    • Lim, Jinyeong;
    • Kim, Sunghoon;
    • Choi, Chel Hun;
    • Kim, Hee Seung;
    • Chung, Jongsuk;
    • Kim, Byoung‐Gie;
    • Lee, Jung‐Yun
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31